CeriBell (CBLL) Expected to Announce Earnings on Tuesday

CeriBell (NASDAQ:CBLL) will likely be releasing its earnings data after the market closes on Tuesday, February 25th. Analysts expect CeriBell to post earnings of ($0.32) per share and revenue of $17.55 million for the quarter. Persons that are interested in registering for the company’s earnings conference call can do so using this link.

CeriBell Stock Up 6.8 %

Shares of CBLL stock opened at $24.69 on Monday. CeriBell has a 1-year low of $18.69 and a 1-year high of $32.75. The business’s fifty day moving average is $23.53.

Wall Street Analyst Weigh In

Several brokerages have weighed in on CBLL. Canaccord Genuity Group started coverage on shares of CeriBell in a report on Tuesday, November 5th. They set a “buy” rating and a $30.00 price objective for the company. TD Cowen lifted their price target on shares of CeriBell from $31.00 to $36.00 and gave the company a “buy” rating in a report on Monday, December 9th. Bank of America started coverage on shares of CeriBell in a report on Tuesday, November 5th. They issued a “buy” rating and a $32.00 price target for the company. JPMorgan Chase & Co. started coverage on shares of CeriBell in a report on Tuesday, November 5th. They issued an “overweight” rating and a $32.00 price target for the company. Finally, William Blair started coverage on shares of CeriBell in a report on Tuesday, November 5th. They issued an “outperform” rating for the company. Six investment analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, CeriBell has an average rating of “Buy” and an average target price of $32.60.

CeriBell Company Profile

We are a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. We have developed the Ceribell System, a novel, point-of-care electroencephalography (“EEG”) platform specifically designed to address the unmet needs of patients in the acute care setting.